The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

Research indicates dietary restriction extends lifespan, prompting exploration of alternatives like rapamycin and metformin.

Rapamycin may match the benefits of eating less. Scientists are now exploring its potential to support healthy aging. The ...

Rapamycin may help prolong life as much as some dietary interventions, according to animal research. These findings, though, ...

A new study published in the American Journal of Obstetrics and Gynaecology revealed that for women with polycystic ovary ...

Metformin and lifestyle intervention was associated with delayed type 2 diabetes onset and slower diabetes progression than placebo.

Turmeric : The dried and ground rhizome (the underground stem) of the Curcuma longa plant. It is a bright yellow-orange spice ...

The anti-aging drug rapamycin has the same life-extending effect as eating less, according to new research from the ...

Rapamycin can extend lifespan across species as effectively as dietary restriction, offering a potential breakthrough in anti ...

Metformin is a type 2 diabetes medication which may impact weight loss. ... effectiveness and metabolic benefits,” adds Sam Setareh, M.D., ...

The anti-aging drug Rapamycin has the same life-extending effect as eating less, according to new research from the University of East Anglia and University of Glasgow.